Athira Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	33.3	32.55	21.23	6.71	1.66	1.42
Research & Development	93.79	61.46	42.79	13.29	3.79	3.59
Other Operating Expenses	-1.63	10	0	0	0	0
Operating Expenses	125.47	104.02	64.02	20	5.45	5.01
Operating Income	-125.47	-104.02	-64.02	-20	-5.45	-5.01
Other Expense / Income	-7.79	-8.38	-9.17	-0.04	-0.29	0.09
Pretax Income	-117.67	-95.64	-54.85	-19.96	-5.16	-5.1
Net Income	-117.67	-95.64	-54.85	-19.96	-5.16	-5.1
Shares Outstanding (Basic)	38	38	37	12	4	3
Shares Outstanding (Diluted)	38	38	37	12	4	3
Shares Change	0.76%	2.20%	208.53%	235.50%	2.82%	-
EPS (Basic)	-3.09	-2.53	-1.49	-1.67	-1.45	-1.47
EPS (Diluted)	-3.09	-2.53	-1.49	-1.67	-1.45	-1.47
Free Cash Flow	-101.06	-73.61	-44.67	-26.43	-3.71	-4.48
Free Cash Flow Per Share	-2.66	-1.95	-1.21	-2.21	-1.04	-1.29
EBITDA	-116.49	-94.59	-54.22	-19.95	-5.16	-5.1
Depreciation & Amortization	1.18	1.05	0.63	0	0	0
EBIT	-117.67	-95.64	-54.85	-19.96	-5.16	-5.1

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).